Current and historical daily PE Ratio for Biocept Inc (
) from 2015 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biocept stock (FRA:B00) PE ratio as of Jun 07 2024 is 0.
More Details
Biocept Inc (FRA:B00) PE Ratio (TTM) Chart
Biocept Inc (FRA:B00) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1133
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| Biocept PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | At Loss | 2023-08-31 | At Loss |
| 2023-11-02 | At Loss | 2023-08-30 | At Loss |
| 2023-11-01 | At Loss | 2023-08-29 | At Loss |
| 2023-10-30 | At Loss | 2023-08-28 | At Loss |
| 2023-10-27 | At Loss | 2023-08-25 | At Loss |
| 2023-10-26 | At Loss | 2023-08-24 | At Loss |
| 2023-10-25 | At Loss | 2023-08-23 | At Loss |
| 2023-10-24 | At Loss | 2023-08-22 | At Loss |
| 2023-10-23 | At Loss | 2023-08-21 | At Loss |
| 2023-10-20 | At Loss | 2023-08-18 | At Loss |
| 2023-10-19 | At Loss | 2023-08-17 | At Loss |
| 2023-10-18 | At Loss | 2023-08-16 | At Loss |
| 2023-10-17 | At Loss | 2023-08-15 | At Loss |
| 2023-10-16 | At Loss | 2023-08-14 | At Loss |
| 2023-10-13 | At Loss | 2023-08-11 | At Loss |
| 2023-10-12 | At Loss | 2023-08-10 | At Loss |
| 2023-10-11 | At Loss | 2023-08-09 | At Loss |
| 2023-10-10 | At Loss | 2023-08-08 | At Loss |
| 2023-10-09 | At Loss | 2023-08-07 | At Loss |
| 2023-10-06 | At Loss | 2023-08-04 | At Loss |
| 2023-10-05 | At Loss | 2023-08-03 | At Loss |
| 2023-10-04 | At Loss | 2023-08-02 | At Loss |
| 2023-10-03 | At Loss | 2023-08-01 | At Loss |
| 2023-10-02 | At Loss | 2023-07-31 | At Loss |
| 2023-09-29 | At Loss | 2023-07-28 | At Loss |
| 2023-09-28 | At Loss | 2023-07-27 | At Loss |
| 2023-09-27 | At Loss | 2023-07-26 | At Loss |
| 2023-09-26 | At Loss | 2023-07-25 | At Loss |
| 2023-09-25 | At Loss | 2023-07-24 | At Loss |
| 2023-09-22 | At Loss | 2023-07-21 | At Loss |
| 2023-09-21 | At Loss | 2023-07-20 | At Loss |
| 2023-09-20 | At Loss | 2023-07-19 | At Loss |
| 2023-09-19 | At Loss | 2023-07-18 | At Loss |
| 2023-09-18 | At Loss | 2023-07-17 | At Loss |
| 2023-09-15 | At Loss | 2023-07-14 | At Loss |
| 2023-09-14 | At Loss | 2023-07-13 | At Loss |
| 2023-09-13 | At Loss | 2023-07-12 | At Loss |
| 2023-09-12 | At Loss | 2023-07-11 | At Loss |
| 2023-09-11 | At Loss | 2023-07-10 | At Loss |
| 2023-09-08 | At Loss | 2023-07-07 | At Loss |
| 2023-09-07 | At Loss | 2023-07-06 | At Loss |
| 2023-09-06 | At Loss | 2023-07-05 | At Loss |
| 2023-09-05 | At Loss | 2023-07-04 | At Loss |
| 2023-09-04 | At Loss | 2023-07-03 | At Loss |
| 2023-09-01 | At Loss | 2023-06-30 | At Loss |
Biocept Inc (FRA:B00) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biocept Inc
NAICS : 621511
SIC : 8731
ISIN : US09072V4023
Description
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers